We're thrilled to announce the latest episode in Laura Hulley's RARE blog, featuring an inspiring interview with Hannah Kurth, founder of Pulse Network! 🌟 In this episode, Hannah shares her incredible journey from economist to pharma innovator, the birth of Pulse Network, and how it's driving innovation and collaboration in the rare disease space💡 👉 https://lnkd.in/ebKjzfkM #RareDisease #LifeSciences #Networking
SciPro’s Post
More Relevant Posts
-
A transformation is underway, powered by innovation and insights. What do you hope to see in our next chapter? Let’s hear your guesses and stay tuned for the big reveal! #HealthcareSolutions #Lifescience #Pharmaconsulting #NewChryselysJourney
To view or add a comment, sign in
-
The latest trends in the diagnostic industry are ushering in an era of innovation. As the industry learns to consistently navigate coverage and reimbursement, the push for advanced diagnostics is enabling healthcare providers to tailor treatments to specific variants. This advancement is not only improving patient outcomes but also enhancing the precision of medicine. Join industry experts Elliott Greenspan, CIO and Co-Founder, @Igentify, Lishan Aklog, MD, Chairman and CEO, Lucid Diagnostics, Rollie Carlson, Ph.D. Carlson, CEO, Immunexpress Inc. Inc and Mike Ward, Head of Thought Leadership for Life Sciences & Healthcare, Clarivate, as they discuss these innovations. https://lnkd.in/ea76Ckak #MedTech #Diagnostics
To view or add a comment, sign in
-
One-time price increases won’t cut it anymore for medtech and diagnostics companies aiming to achieve pricing excellence. So, what’s the way forward? Read our latest blog for key insights from our 2024 Global Pricing Study, guiding you toward sustainable growth in medtech and diagnostics. More here: https://ow.ly/wgFN50S9tLY #GlobalPricingStudy #Medtech #Diagnostics #SimonKucher #PricingStrategy
To view or add a comment, sign in
-
One-time price increases won’t cut it anymore for medtech and diagnostics companies aiming to achieve pricing excellence. So, what’s the way forward? Read our latest blog for key insights from our 2024 Global Pricing Study, guiding you toward sustainable growth in medtech and diagnostics. More here: skp.link/gxy #GlobalPricingStudy #Medtech #Diagnostics #SimonKucher #PricingStrategy
To view or add a comment, sign in
-
Calling all Healthcare & Life Sciences Founders! Are you ready to dive deep into the truths, triumphs, and trials of building a successful startup? Join the insightful discussions at Healthcare Truths, Triumphs, & Trials on March 13th from 2:00pm to 6:30pm. ️ • Hear unfiltered truths from seasoned founders in "Founder Truths." • Learn critical risk mitigation strategies to protect your team and business. • Gain invaluable insights on from Venture Capitalists in "Why VCs Say No." Whether you're just starting out or facing scaling challenges, this event is packed with actionable guidance and invaluable connections. Don't miss out! Register now: https://lnkd.in/erx7Btcr See you there! #healthtech #medtech #lifesciences #biotech #techbio #digitaltherapeutics #diagnostics #therapeutics #digitalhealth #founderjourney P.S. Share this post with your fellow healthcare & life sciences founders!
#Founders, join the conversation at Healthcare Truths, Triumphs, & Trials Click the link below to register for our upcoming panel discussions where industry leaders and visionaries will dive deep into the intricacies of the healthcare sector. 📅 Date: 13 March 🕒 Time: 2:00pm – 6:30pm 🔗 Registration Link: https://lnkd.in/erx7Btcr Panel discussions Founder Truths: A frank discussion on the realities of the founder journey Mitigating Risk: How to protect you, your team and business Why VCs Say No: Understand why VCs don’t invest and what makes them say yes #healthtech, #medtech, #lifesciences, #biotech, #techbio, #digitaltherapeutics, #diagnosics, #digitalhealth, #founderjourney
To view or add a comment, sign in
-
🔬Life Sciences and MedTech companies face a critical challenge: understanding the real-world impact of therapeutics on patients after market entry. 💡 Lynx.MD is bridging the gap between healthcare partners and Life Sciences/MedTech innovators to bring real-world longitudinal data that delivers the insights you need now to understand patient outcomes. 📊🤝 Ready to explore the future of healthcare? Swipe through our infographic to preview the data assets we bring to innovation. 🚀 👉 Contact our team on LinkedIn today, Collin Labar, Robert Eisdorfer, MD, @Jody Bare. https://lynx.md/ #RealWorldData #LifeSciences #MedTech #HealthcareInnovation #PatientOutcomes #LynxMD
To view or add a comment, sign in
-
“𝙒𝙚 𝙘𝙝𝙖𝙣𝙜𝙚 𝙩𝙝𝙚 𝙙𝙧𝙪𝙜 𝙙𝙞𝙨𝙘𝙤𝙫𝙚𝙧𝙮 𝙥𝙖𝙧𝙖𝙙𝙞𝙜𝙢 𝙛𝙧𝙤𝙢 𝙗𝙚𝙞𝙣𝙜 𝙖 𝙘𝙧𝙞𝙨𝙞𝙨-𝙡𝙚𝙙 𝙖𝙘𝙩𝙞𝙫𝙞𝙩𝙮 𝙩𝙤 𝙗𝙚𝙞𝙣𝙜 𝙖 𝙨𝙩𝙧𝙖𝙩𝙚𝙜𝙞𝙘𝙖𝙡𝙡𝙮-𝙡𝙚𝙙 𝙖𝙘𝙩𝙞𝙫𝙞𝙩𝙮 ... 𝙖𝙣 𝙖𝙫𝙤𝙞𝙙𝙖𝙣𝙘𝙚 𝙤𝙛 𝙙𝙞𝙨𝙚𝙖𝙨𝙚, 𝙬𝙝𝙞𝙘𝙝 𝙨𝙖𝙫𝙚𝙨 𝙢𝙤𝙣𝙚𝙮 𝙛𝙤𝙧 𝙩𝙝𝙚 𝙝𝙚𝙖𝙡𝙩𝙝𝙘𝙖𝙧𝙚 𝙥𝙖𝙮𝙚𝙧 𝙖𝙣𝙙 𝙞𝙣𝙘𝙧𝙚𝙖𝙨𝙚𝙨 𝙦𝙪𝙖𝙡𝙞𝙩𝙮 𝙤𝙛 𝙡𝙞𝙛𝙚 𝙛𝙤𝙧 𝙞𝙣𝙙𝙞𝙫𝙞𝙙𝙪𝙖𝙡.” In today’s “𝗦𝗻𝗮𝗽𝘀𝗵𝗼𝘁𝘀 𝗙𝗿𝗼𝗺 𝗧𝗵𝗲 𝗘𝗱𝗴𝗲” LifeTech leadership video, David Pardoe, SVP and Head of Global Molecular Architects at Evotec, explains how everyday data captured via smartphone has the genuine potential to transform both disease prediction and prevention. #diseaseprediction #diseaseprevention #LifeScience #lifetech #SnapshotsFromTheEdge
To view or add a comment, sign in
-
check out the blog post by my colleague Sofie Vandevyver, PhD about the journey behind our new brand and graphic identity!
Recently, we launched our redesigned website and refreshed brand, showcasing not just a new look, but a renewed commitment to driving success in drug development and commercialization, and improving patient outcomes. ✍️ In our latest blog, Sofie Vandevyver, PhD, Vice President and Global Head of Marketing at Cytel, explains the reasons behind our transformation and the core elements of our new brand. And that's not all! 💡Sofie dives into the hottest industry trends and reveals how we are uniquely positioned to help you unlock the full potential of therapies. Read the full article: https://bit.ly/4cxJIaE #DataScience #DrugDevelopment #NewCytel #Transformation #PatientOutcomes
To view or add a comment, sign in
-
Igentify’s CIO and Co-Founder Elliott Greenspan recently joined Mike Ward of Clarivate on a roundtable to discuss challenges and opportunities associated with diagnostics. Tune in to explore the exciting future of diagnostics: 🧬 Lessons from COVID-19: What did we learn from ramping up testing? 🧬 Investment & Collaboration: How is this experience changing partnerships? 🧬 Precision Medicine: How are diagnostics paving the way for personalized treatments? 🧬 Challenges & Opportunities: Regulatory hurdles and advancements in patient care. https://lnkd.in/enpysrYX #diagnostics #webinar #precisionmedicine #geneticcounseling
To view or add a comment, sign in
-
Making cardiac diagnostics stress free!
Genetesis is excited to announce that our co-founder and CEO, Peeyush Shrivastava has been selected to speak at #LSIUSA24. We’re looking forward to connecting with other leaders passionate about advancing technology in healthcare. See you at our session on March 21 in track 4 at 1 pm! 🧠
To view or add a comment, sign in
98,140 followers